These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14585518)

  • 21. Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1.
    Stringer JS; Sinkala M; Goldenberg R; Vermund S; Acosta E
    Lancet; 2003 Aug; 362(9384):667. PubMed ID: 12944077
    [No Abstract]   [Full Text] [Related]  

  • 22. Maternal Influences on Access to and Use of Infant ARVs and HIV Health Services in Uganda.
    Bergmann JN; Wanyenze RK; Makumbi F; Naigino R; Kiene SM; Stockman JK
    AIDS Behav; 2017 Sep; 21(9):2693-2702. PubMed ID: 27553030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Maternal self-medication and provision of nevirapine to newborns by women in Rakai, Uganda.
    Kagaayi J; Dreyfuss ML; Kigozi G; Chen MZ; Wabwire-Mangen F; Serwadda D; Wawer MJ; Sewankambo NK; Nalugoda F; Kiwanuka N; Kiddugavu M; Gray RH
    J Acquir Immune Defic Syndr; 2005 May; 39(1):121-4. PubMed ID: 15851922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preventing mother-to-child transmission of HIV: successes and challenges.
    McIntyre J
    BJOG; 2005 Sep; 112(9):1196-203. PubMed ID: 16101596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The controversies of nevirapine for preventing mother-to-child HIV transmission.
    Smith DM
    AIDS; 2006 Jan; 20(2):281-3. PubMed ID: 16511423
    [No Abstract]   [Full Text] [Related]  

  • 26. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I; Lockman S; Smeaton LM; Shapiro RL; Wester C; Heymann SJ; Gilbert PB; Stevens L; Peter T; Kim S; van Widenfelt E; Moffat C; Ndase P; Arimi P; Kebaabetswe P; Mazonde P; Makhema J; McIntosh K; Novitsky V; Lee TH; Marlink R; Lagakos S; Essex M;
    JAMA; 2006 Aug; 296(7):794-805. PubMed ID: 16905785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk].
    MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137
    [No Abstract]   [Full Text] [Related]  

  • 29. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R; Paredes R; Parboosing R; Moodley P; Gordon M
    AIDS Rev; 2014; 16(4):187-98. PubMed ID: 25300623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C; Rampon O; De Rossi A
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
    Tudor Car L; van-Velthoven MH; Brusamento S; Elmoniry H; Car J; Majeed A; Atun R
    Cochrane Database Syst Rev; 2011 Jun; (6):CD008741. PubMed ID: 21678382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in women exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV: a stochastic model.
    Westreich D; Eron J; Behets F; Horst Cv; Van Rie A
    J Infect Dis; 2007 Mar; 195(6):837-46. PubMed ID: 17299714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake and performance of prevention of mother-to-child transmission and early infant diagnosis in pregnant HIV-infected women and their exposed infants at seven health centres in Addis Ababa, Ethiopia.
    Girma M; Wendaferash R; Shibru H; Berhane Y; Hoelscher M; Kroidl A
    Trop Med Int Health; 2017 Jun; 22(6):765-775. PubMed ID: 28407452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
    Eshleman SH; Becker-Pergola G; Deseyve M; Guay LA; Mracna M; Fleming T; Cunningham S; Musoke P; Mmiro F; Jackson JB
    J Infect Dis; 2001 Oct; 184(7):914-7. PubMed ID: 11509999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Easier said than done: World Health Organization recommendations for prevention of mother-to-child transmission of HIV-areas of concern.
    Palombi L; Nielsen-Saines K; Giuliano M; Marazzi MC
    AIDS Res Hum Retroviruses; 2011 Aug; 27(8):807-8. PubMed ID: 21142813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa.
    Marseille E; Kahn JG; Mmiro F; Guay L; Musoke P; Fowler MG; Jackson JB
    Lancet; 1999 Sep; 354(9181):803-9. PubMed ID: 10485721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability and utilisation of voluntary HIV testing and nevirapine to reduce mother-to-child transmission of HIV-1 integrated into routine clinical care.
    Urban M; Chersich M
    S Afr Med J; 2004 May; 94(5):362-6. PubMed ID: 15211956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF; Castelo A; Martínez M
    AIDS Rev; 2011; 13(4):198-213. PubMed ID: 21975356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.